Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 171 to 180 of 249 resources
-
Camden Liver Disease Profile
This document, produced by Public Health England, provides an overview of liver disease in Camden. It includes key facts on hepatitis C in Camden, as well as a section on 'Questions you should ask locally', which aims to improve local prioritisation and management of hepatitis C.UK, England, Greater London Nov 2014 Reports & Research PDF -
Nottinghamshire Liver Disease Profile
This document, produced by Public Health England, provides an overview of liver disease in Nottinghamshire. It includes key facts on hepatitis C in Nottinghamshire, as well as a section on 'Questions you should ask locally', which aims to improve local prioritisation and management of hepatitis C.UK, England, East of England Nov 2014 Reports & Research PDF -
Shooting up Infections among people who inject drugs in the United Kingdom 2013: An update November 2014
A Public Health England update on the 2013 report, highlighting that hepatitis C levels are still high; that hepatitis B is now rare and vaccine uptake has improved; that HIV levels remain low and the uptake of care is good; that bacterial infections remain a major problem; that injecting risk behaviours have declined but remain a problem; and that changing patterns of psychoactive drug injection are a cause for concern. The report recommends that the provision of effective interventions need to be maintained.England Nov 2014 Reports & Research PDF -
Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions
This study, funded by the Scottish Government, sought to determine whether trends in the proportion of injectors newly infected with hepatitis C in Scotland between 2008 and 2012 could be linked to the adequacy of provision of sterile injecting equipment and of methadone maintenance treatment. It found that impressive reductions in hepatitis C incidence can be achieved among PWID over a relatively short time period through high coverage of a combination of harm reduction interventions.UK, Scotland Sep 2014 Reports & Research PDF -
Hepatitis C in the UK 2014 report
This annual Hepatitis C in the UK report provides detail on the scale of the problem in 2014; prevention of infection in people who inject drugs (PWIDs); diagnosis, testing and awareness of infection; and access to treatment and care.UK Jul 2014 Reports & Research PDF -
Health and Wellbeing Boards & Hepatitis C
This report by HCV Action investigates the prioritisation of hepatitis C virus (HCV) infection by Health and Wellbeing Boards (HWBs) across England. The aim of the review is to compare the extent to which local authorities have considered the diagnosis and treatment of hepatitis C in their area, in order to identify the range of local commissioning and treatment practices that exist across England. Evidence was gathered from the most recent Joint Strategic Needs Assessments (JSNA) and Joint Health and Wellbeing Strategies (JHWS) available from local authorities.UK 14 May 2014 Reports & Research, Strategy & Planning PDF -
EASL Recommendations on Treatment of Hepatitis C: 2014
These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decisionmaking process by describing the optimal management of patients with acute and chronic HCV infections. These guidelines apply to therapies that will be approved within less than 6 months at the time of their publication.UK Apr 2014 Reports & Research, Tools & Templates, Strategy & Planning PDF -
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
These EASL Clinical Practice Guidelines (CPGs) are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the optimal management of patients with acute and chronic HCV infections. These guidelines apply to therapies that are approved at the time of their publication.UK, Rest of World 2014 Training, Reports & Research, Tools & Templates PDF -
Liver Disease: Today's Complacency, Tomorrow's Catastrophe. The All-Party Parliamentary Hepatology Group (APPHG) Inquiry into Improving Outcomes in Liver Disease
Out of disappointment at the persistent failure to develop a comprehensive approach to tackling liver disease, The All-Party Parliamentary Hepatology Group (APPHG) decided to conduct a comprehensive inquiry into the growing epidemic of liver disease. It invited evidence from Royal Colleges, clinicians, patients, charities, relevant industry figures, the NHS, Public Health England and the Government, in order to establish what needs to be done to improve outcomes for liver disease patients and save lives.UK 25 Mar 2014 Reports & Research PDF -
Hepatitis C Setting Standards in a Journey towards the Eradication of Infection and Disease as a Serious Health Issue in the EU
Initiatives which translate evidence and strategy into Hepatitis C Action are few and far between in the EU.UK, Rest of World 2014 Reports & Research, Strategy & Planning PDF